Reflect Scientific, Inc. (RSCF)
0.0558
-0.01
(-11.99%)
USD |
OTCM |
Nov 18, 16:00
Reflect Scientific Enterprise Value : 3.033M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 3.033M |
| November 17, 2026 | 3.684M |
| November 16, 2026 | 3.221M |
| November 13, 2026 | 3.221M |
| November 12, 2026 | 3.221M |
| November 11, 2026 | 3.377M |
| November 10, 2026 | 3.572M |
| November 09, 2026 | 3.569M |
| November 06, 2026 | 3.020M |
| November 05, 2026 | 3.341M |
| November 04, 2026 | 3.332M |
| November 03, 2026 | 2.836M |
| November 02, 2026 | 2.861M |
| October 30, 2026 | 3.272M |
| October 29, 2026 | 3.272M |
| October 28, 2026 | 3.124M |
| October 27, 2026 | 3.223M |
| October 26, 2026 | 3.223M |
| October 23, 2026 | 3.223M |
| October 22, 2026 | 3.384M |
| October 21, 2026 | 3.632M |
| October 20, 2026 | 3.632M |
| October 19, 2026 | 3.123M |
| October 16, 2026 | 3.684M |
| October 15, 2026 | 3.649M |
| Date | Value |
|---|---|
| October 14, 2026 | 3.401M |
| October 13, 2026 | 3.433M |
| October 12, 2026 | 3.007M |
| October 09, 2026 | 2.956M |
| October 08, 2026 | 2.621M |
| October 07, 2026 | 2.835M |
| October 06, 2026 | 2.960M |
| October 05, 2026 | 2.536M |
| October 02, 2026 | 2.328M |
| October 01, 2026 | 2.707M |
| September 30, 2026 | 3.317M |
| September 29, 2026 | 3.701M |
| September 28, 2026 | 3.684M |
| September 25, 2026 | 3.687M |
| September 24, 2026 | 3.538M |
| September 23, 2026 | 3.624M |
| September 22, 2026 | 3.966M |
| September 21, 2026 | 3.624M |
| September 18, 2026 | 3.290M |
| September 17, 2026 | 2.99M |
| September 16, 2026 | 2.939M |
| September 15, 2026 | 2.639M |
| September 14, 2026 | 2.082M |
| September 11, 2026 | 2.425M |
| September 10, 2026 | 2.467M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 28.05B |
| Agilent Technologies, Inc. | 52.19B |
| Anika Therapeutics, Inc. | 163.62M |
| Bio-Rad Laboratories, Inc. | 9.652B |
| Bruker Corp. | 11.26B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.2701M |
| Revenue (Quarterly) | 0.6301M |
| Total Expenses (Quarterly) | 0.3601M |
| EPS Diluted (Quarterly) | 0.0032 |
| Gross Profit Margin (Quarterly) | 54.67% |
| Profit Margin (Quarterly) | 42.87% |
| Earnings Yield | 11.65% |
| Operating Earnings Yield | 10.37% |
| Normalized Earnings Yield | 11.47 |